High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-08-24

AUTHORS

Paolo Zocca, Marlies M. Kok, Liefke C. van der Heijden, Peter W. Danse, Carl E. Schotborgh, Martijn Scholte, Marc Hartmann, Gerard C. M. Linssen, Carine J. M. Doggen, Clemens von Birgelen

ABSTRACT

PurposePatients with high bleeding risk (HBR) who undergo percutaneous coronary intervention also have an increased risk of ischemic events and represent an overall high-risk population. The coating of durable polymer drug-eluting stents (DP-DES) may induce inflammation and delay arterial healing, which might be reduced by novel biodegradable polymer DES (BP-DES). We aimed to evaluate the safety and efficacy of treating HBR patients with very thin-strut BP-DES versus thin-strut DP-DES.MethodsParticipants in BIO-RESORT (NCT01674803), an investigator-initiated multicenter, randomized all-comers trial, were treated with very thin-strut BP-DES (Synergy or Orsiro) or thin-strut DP-DES (Resolute Integrity). For the present analysis, patients were classified following HBR criteria based on previous trials. The primary endpoint was target vessel failure: a composite of cardiac death, target vessel-related myocardial infarction, or target vessel revascularization at 1 year.ResultsOf all 3514 patients, 1009 (28.7%) had HBR. HBR patients were older (p < 0.001) and had more co-morbidities than non-HBR patients (p < 0.001). At 1-year follow-up, HBR patients had significantly higher rates of target vessel failure (6.7 vs. 4.2%, p = 0.003), cardiac death (1.9 vs. 0.4%, p < 0.001), and major bleeding (3.3 vs. 1.5%, p = 0.001). Of all 1009 HBR patients, 673 (66.7%) received BP-DES and 336 (33.3%) had DP-DES. The primary endpoint was met by 43/673 (6.5%) patients treated with BP-DES and 24/336 (7.3%) treated with DP-DES (HR 0.88 [95%CI 0.54–1.46], p = 0.63). There were no significant between-group differences in the most global patient-oriented clinical endpoint (9.7 vs. 10.5%, HR 0.92 [95%CI 0.61–1.39], p = 0.69) and other secondary endpoints.ConclusionsAt 1-year follow-up, very thin-strut BP-DES showed similar safety and efficacy for treating HBR patients as thin-strut DP-DES. More... »

PAGES

567-576

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10557-018-6823-9

DOI

http://dx.doi.org/10.1007/s10557-018-6823-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106329900

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30143879


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Absorbable Implants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Artery Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Eluting Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Netherlands", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Percutaneous Coronary Intervention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prosthesis Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zocca", 
        "givenName": "Paolo", 
        "id": "sg:person.07360604275.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07360604275.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kok", 
        "givenName": "Marlies M.", 
        "id": "sg:person.0660011420.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660011420.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van der Heijden", 
        "givenName": "Liefke C.", 
        "id": "sg:person.0611676220.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611676220.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Rijnstate Hospital, Arnhem, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415930.a", 
          "name": [
            "Department of Cardiology, Rijnstate Hospital, Arnhem, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Danse", 
        "givenName": "Peter W.", 
        "id": "sg:person.0752260563.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752260563.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Haga Hospital, Den Haag, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.413591.b", 
          "name": [
            "Department of Cardiology, Haga Hospital, Den Haag, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schotborgh", 
        "givenName": "Carl E.", 
        "id": "sg:person.0634373652.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634373652.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.413972.a", 
          "name": [
            "Department of Cardiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scholte", 
        "givenName": "Martijn", 
        "id": "sg:person.0622022030.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622022030.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hartmann", 
        "givenName": "Marc", 
        "id": "sg:person.01371270365.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371270365.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Ziekenhuisgroep Twente, Almelo and Hengelo, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.417370.6", 
          "name": [
            "Department of Cardiology, Ziekenhuisgroep Twente, Almelo and Hengelo, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Linssen", 
        "givenName": "Gerard C. M.", 
        "id": "sg:person.012615570741.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012615570741.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Doggen", 
        "givenName": "Carine J. M.", 
        "id": "sg:person.01146757520.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146757520.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, the Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands", 
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Birgelen", 
        "givenName": "Clemens", 
        "id": "sg:person.0600054325.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600054325.83"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10557-014-6528-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004274264", 
          "https://doi.org/10.1007/s10557-014-6528-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-14247-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092446402", 
          "https://doi.org/10.1038/s41598-017-14247-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-08-24", 
    "datePublishedReg": "2018-08-24", 
    "description": "PurposePatients with high bleeding risk (HBR) who undergo percutaneous coronary intervention also have an increased risk of ischemic events and represent an overall high-risk population. The coating of durable polymer drug-eluting stents (DP-DES) may induce inflammation and delay arterial healing, which might be reduced by novel biodegradable polymer DES (BP-DES). We aimed to evaluate the safety and efficacy of treating HBR patients with very thin-strut BP-DES versus thin-strut DP-DES.MethodsParticipants in BIO-RESORT (NCT01674803), an investigator-initiated multicenter, randomized all-comers trial, were treated with very thin-strut BP-DES (Synergy or Orsiro) or thin-strut DP-DES (Resolute Integrity). For the present analysis, patients were classified following HBR criteria based on previous trials. The primary endpoint was target vessel failure: a composite of cardiac death, target vessel-related myocardial infarction, or target vessel revascularization at 1\u00a0year.ResultsOf all 3514 patients, 1009 (28.7%) had HBR. HBR patients were older (p\u2009<\u20090.001) and had more co-morbidities than non-HBR patients (p\u2009<\u20090.001). At 1-year follow-up, HBR patients had significantly higher rates of target vessel failure (6.7 vs. 4.2%, p\u2009=\u20090.003), cardiac death (1.9 vs. 0.4%, p\u2009<\u20090.001), and major bleeding (3.3 vs. 1.5%, p\u2009=\u20090.001). Of all 1009 HBR patients, 673 (66.7%) received BP-DES and 336 (33.3%) had DP-DES. The primary endpoint was met by 43/673 (6.5%) patients treated with BP-DES and 24/336 (7.3%) treated with DP-DES (HR 0.88 [95%CI 0.54\u20131.46], p\u2009=\u20090.63). There were no significant between-group differences in the most global patient-oriented clinical endpoint (9.7 vs. 10.5%, HR 0.92 [95%CI 0.61\u20131.39], p\u2009=\u20090.69) and other secondary endpoints.ConclusionsAt 1-year follow-up, very thin-strut BP-DES showed similar safety and efficacy for treating HBR patients as thin-strut DP-DES.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10557-018-6823-9", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097576", 
        "issn": [
          "0920-3206", 
          "1573-7241"
        ], 
        "name": "Cardiovascular Drugs and Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "keywords": [
      "high bleeding risk", 
      "target vessel failure", 
      "HBR patients", 
      "BP-DES", 
      "DP-DES", 
      "primary endpoint", 
      "cardiac death", 
      "durable polymer drug-eluting stents", 
      "target vessel-related myocardial infarction", 
      "vessel-related myocardial infarction", 
      "high bleeding risk patients", 
      "thin-strut biodegradable polymer", 
      "significant between-group differences", 
      "investigator-initiated multicenter", 
      "non-HBR patients", 
      "percutaneous coronary intervention", 
      "high-risk population", 
      "between-group differences", 
      "drug-eluting stents", 
      "biodegradable polymer DES", 
      "BIO-RESORT", 
      "HBR criteria", 
      "major bleeding", 
      "bleeding risk", 
      "vessel revascularization", 
      "secondary endpoints", 
      "coronary intervention", 
      "ischemic events", 
      "risk patients", 
      "comers trial", 
      "similar safety", 
      "vessel failure", 
      "myocardial infarction", 
      "clinical endpoints", 
      "patients", 
      "arterial healing", 
      "eluting stents", 
      "previous trials", 
      "endpoint", 
      "trials", 
      "high rate", 
      "stents", 
      "efficacy", 
      "death", 
      "risk", 
      "polymer drug", 
      "safety", 
      "multicenter", 
      "revascularization", 
      "PurposePatients", 
      "bleeding", 
      "infarction", 
      "inflammation", 
      "failure", 
      "MethodsParticipants", 
      "drugs", 
      "intervention", 
      "healing", 
      "ConclusionsAt", 
      "population", 
      "years", 
      "present analysis", 
      "differences", 
      "criteria", 
      "rate", 
      "events", 
      "DES", 
      "analysis", 
      "biodegradable polymers", 
      "composites", 
      "coatings", 
      "polymers"
    ], 
    "name": "High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial", 
    "pagination": "567-576", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106329900"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10557-018-6823-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30143879"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10557-018-6823-9", 
      "https://app.dimensions.ai/details/publication/pub.1106329900"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T21:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_785.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10557-018-6823-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10557-018-6823-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10557-018-6823-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10557-018-6823-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10557-018-6823-9'


 

This table displays all metadata directly associated to this object as RDF triples.

296 TRIPLES      21 PREDICATES      118 URIs      108 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10557-018-6823-9 schema:about N0046f685f706497bbafa03d587e254ea
2 N1f302414bc9840528b193a93da50bc19
3 N49fe10e74c9c4d3ead2210a772f6a40d
4 N4f63164b24064836a188dd9c8e5b873a
5 N517434b0eea041ee9a8c1b0930b922cb
6 N5dba6101da674c059f69822a1f705ca4
7 N5eb2c52d4c3348e9b682a2b69b598d77
8 N79314f3a16f145248f0c45e717eed9aa
9 N81f48ab7ed934f8c8f5d92afa95708a3
10 N900e9fa42c2642fcbbab0700d2f04329
11 N96090ce9ddb54eab8d108fe1c4c0f226
12 Na26eb33d9b3b4549b4b3bd07080c22fd
13 Na393c61dc1f9405b82dae3728f3c4e0c
14 Na5adc3aab84a4d179d74d88ec5b79eee
15 Nb38a1315352b47cb87b438afb12834b0
16 Nb7bdfbddfefa45fd94841a6e4ea82e77
17 Ne019323988674e9a922cad6ff6622c6f
18 Ne27debfb8079463c9d584203b2005e2a
19 Nfd5f1a8db33d42d08aead9b4ce98c9fd
20 anzsrc-for:11
21 anzsrc-for:1102
22 schema:author N9a3b9ae648da4faab446a7bba7b3666e
23 schema:citation sg:pub.10.1007/s10557-014-6528-7
24 sg:pub.10.1038/s41598-017-14247-6
25 schema:datePublished 2018-08-24
26 schema:datePublishedReg 2018-08-24
27 schema:description PurposePatients with high bleeding risk (HBR) who undergo percutaneous coronary intervention also have an increased risk of ischemic events and represent an overall high-risk population. The coating of durable polymer drug-eluting stents (DP-DES) may induce inflammation and delay arterial healing, which might be reduced by novel biodegradable polymer DES (BP-DES). We aimed to evaluate the safety and efficacy of treating HBR patients with very thin-strut BP-DES versus thin-strut DP-DES.MethodsParticipants in BIO-RESORT (NCT01674803), an investigator-initiated multicenter, randomized all-comers trial, were treated with very thin-strut BP-DES (Synergy or Orsiro) or thin-strut DP-DES (Resolute Integrity). For the present analysis, patients were classified following HBR criteria based on previous trials. The primary endpoint was target vessel failure: a composite of cardiac death, target vessel-related myocardial infarction, or target vessel revascularization at 1 year.ResultsOf all 3514 patients, 1009 (28.7%) had HBR. HBR patients were older (p < 0.001) and had more co-morbidities than non-HBR patients (p < 0.001). At 1-year follow-up, HBR patients had significantly higher rates of target vessel failure (6.7 vs. 4.2%, p = 0.003), cardiac death (1.9 vs. 0.4%, p < 0.001), and major bleeding (3.3 vs. 1.5%, p = 0.001). Of all 1009 HBR patients, 673 (66.7%) received BP-DES and 336 (33.3%) had DP-DES. The primary endpoint was met by 43/673 (6.5%) patients treated with BP-DES and 24/336 (7.3%) treated with DP-DES (HR 0.88 [95%CI 0.54–1.46], p = 0.63). There were no significant between-group differences in the most global patient-oriented clinical endpoint (9.7 vs. 10.5%, HR 0.92 [95%CI 0.61–1.39], p = 0.69) and other secondary endpoints.ConclusionsAt 1-year follow-up, very thin-strut BP-DES showed similar safety and efficacy for treating HBR patients as thin-strut DP-DES.
28 schema:genre article
29 schema:isAccessibleForFree true
30 schema:isPartOf N12acca39ec0240cf99ec1ec347c8ea43
31 Na4fe95acc5304aaf9c5e358d23b0ea9a
32 sg:journal.1097576
33 schema:keywords BIO-RESORT
34 BP-DES
35 ConclusionsAt
36 DES
37 DP-DES
38 HBR criteria
39 HBR patients
40 MethodsParticipants
41 PurposePatients
42 analysis
43 arterial healing
44 between-group differences
45 biodegradable polymer DES
46 biodegradable polymers
47 bleeding
48 bleeding risk
49 cardiac death
50 clinical endpoints
51 coatings
52 comers trial
53 composites
54 coronary intervention
55 criteria
56 death
57 differences
58 drug-eluting stents
59 drugs
60 durable polymer drug-eluting stents
61 efficacy
62 eluting stents
63 endpoint
64 events
65 failure
66 healing
67 high bleeding risk
68 high bleeding risk patients
69 high rate
70 high-risk population
71 infarction
72 inflammation
73 intervention
74 investigator-initiated multicenter
75 ischemic events
76 major bleeding
77 multicenter
78 myocardial infarction
79 non-HBR patients
80 patients
81 percutaneous coronary intervention
82 polymer drug
83 polymers
84 population
85 present analysis
86 previous trials
87 primary endpoint
88 rate
89 revascularization
90 risk
91 risk patients
92 safety
93 secondary endpoints
94 significant between-group differences
95 similar safety
96 stents
97 target vessel failure
98 target vessel-related myocardial infarction
99 thin-strut biodegradable polymer
100 trials
101 vessel failure
102 vessel revascularization
103 vessel-related myocardial infarction
104 years
105 schema:name High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial
106 schema:pagination 567-576
107 schema:productId N0734dc66c2a44a9399a8a7bbe2d9e8f4
108 N0e0a946a0ca1442aa5d135e97b06f6b2
109 N3d34a3d451bb41e9ae463d54e3ecf182
110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106329900
111 https://doi.org/10.1007/s10557-018-6823-9
112 schema:sdDatePublished 2022-11-24T21:03
113 schema:sdLicense https://scigraph.springernature.com/explorer/license/
114 schema:sdPublisher Nd0adc78d5aa445fbb7d922e08f7ba12b
115 schema:url https://doi.org/10.1007/s10557-018-6823-9
116 sgo:license sg:explorer/license/
117 sgo:sdDataset articles
118 rdf:type schema:ScholarlyArticle
119 N0046f685f706497bbafa03d587e254ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Absorbable Implants
121 rdf:type schema:DefinedTerm
122 N0734dc66c2a44a9399a8a7bbe2d9e8f4 schema:name doi
123 schema:value 10.1007/s10557-018-6823-9
124 rdf:type schema:PropertyValue
125 N0c11a6bbeb394ecc904d563fd3fa4538 rdf:first sg:person.01371270365.96
126 rdf:rest Nb880aa603daa40da935082bbe3f10e41
127 N0e0a946a0ca1442aa5d135e97b06f6b2 schema:name dimensions_id
128 schema:value pub.1106329900
129 rdf:type schema:PropertyValue
130 N0ff8c0119c374cc28afc3d812309f6bb rdf:first sg:person.0660011420.13
131 rdf:rest N7b5e95788dd1400086438a9a4253566c
132 N12acca39ec0240cf99ec1ec347c8ea43 schema:issueNumber 6
133 rdf:type schema:PublicationIssue
134 N1f302414bc9840528b193a93da50bc19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Risk Factors
136 rdf:type schema:DefinedTerm
137 N2e206ebc763c4681bdbe26eb4a2820d3 rdf:first sg:person.0752260563.26
138 rdf:rest N8ceca2abde2940e19ef3682221f34505
139 N3d34a3d451bb41e9ae463d54e3ecf182 schema:name pubmed_id
140 schema:value 30143879
141 rdf:type schema:PropertyValue
142 N49fe10e74c9c4d3ead2210a772f6a40d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Time Factors
144 rdf:type schema:DefinedTerm
145 N4eb88ea57d0841b1bfa2dcd36974c3a9 rdf:first sg:person.0622022030.42
146 rdf:rest N0c11a6bbeb394ecc904d563fd3fa4538
147 N4f63164b24064836a188dd9c8e5b873a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Middle Aged
149 rdf:type schema:DefinedTerm
150 N517434b0eea041ee9a8c1b0930b922cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Treatment Outcome
152 rdf:type schema:DefinedTerm
153 N5dba6101da674c059f69822a1f705ca4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Polymers
155 rdf:type schema:DefinedTerm
156 N5eb2c52d4c3348e9b682a2b69b598d77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Drug-Eluting Stents
158 rdf:type schema:DefinedTerm
159 N66535eb02f6749d0afa9faae256d09be rdf:first sg:person.0600054325.83
160 rdf:rest rdf:nil
161 N79314f3a16f145248f0c45e717eed9aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Female
163 rdf:type schema:DefinedTerm
164 N7b5e95788dd1400086438a9a4253566c rdf:first sg:person.0611676220.78
165 rdf:rest N2e206ebc763c4681bdbe26eb4a2820d3
166 N81f48ab7ed934f8c8f5d92afa95708a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Hemorrhage
168 rdf:type schema:DefinedTerm
169 N8ceca2abde2940e19ef3682221f34505 rdf:first sg:person.0634373652.04
170 rdf:rest N4eb88ea57d0841b1bfa2dcd36974c3a9
171 N900e9fa42c2642fcbbab0700d2f04329 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Male
173 rdf:type schema:DefinedTerm
174 N96090ce9ddb54eab8d108fe1c4c0f226 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Risk Assessment
176 rdf:type schema:DefinedTerm
177 N9a3b9ae648da4faab446a7bba7b3666e rdf:first sg:person.07360604275.78
178 rdf:rest N0ff8c0119c374cc28afc3d812309f6bb
179 Na26eb33d9b3b4549b4b3bd07080c22fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Aged
181 rdf:type schema:DefinedTerm
182 Na393c61dc1f9405b82dae3728f3c4e0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Coronary Artery Disease
184 rdf:type schema:DefinedTerm
185 Na4fe95acc5304aaf9c5e358d23b0ea9a schema:volumeNumber 32
186 rdf:type schema:PublicationVolume
187 Na5adc3aab84a4d179d74d88ec5b79eee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Netherlands
189 rdf:type schema:DefinedTerm
190 Nb38a1315352b47cb87b438afb12834b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Platelet Aggregation Inhibitors
192 rdf:type schema:DefinedTerm
193 Nb7bdfbddfefa45fd94841a6e4ea82e77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Percutaneous Coronary Intervention
195 rdf:type schema:DefinedTerm
196 Nb880aa603daa40da935082bbe3f10e41 rdf:first sg:person.012615570741.59
197 rdf:rest Nc9858132418b4d3b86c94fb408da2539
198 Nc9858132418b4d3b86c94fb408da2539 rdf:first sg:person.01146757520.17
199 rdf:rest N66535eb02f6749d0afa9faae256d09be
200 Nd0adc78d5aa445fbb7d922e08f7ba12b schema:name Springer Nature - SN SciGraph project
201 rdf:type schema:Organization
202 Ne019323988674e9a922cad6ff6622c6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Prosthesis Design
204 rdf:type schema:DefinedTerm
205 Ne27debfb8079463c9d584203b2005e2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Aged, 80 and over
207 rdf:type schema:DefinedTerm
208 Nfd5f1a8db33d42d08aead9b4ce98c9fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Humans
210 rdf:type schema:DefinedTerm
211 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
212 schema:name Medical and Health Sciences
213 rdf:type schema:DefinedTerm
214 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
215 schema:name Cardiorespiratory Medicine and Haematology
216 rdf:type schema:DefinedTerm
217 sg:journal.1097576 schema:issn 0920-3206
218 1573-7241
219 schema:name Cardiovascular Drugs and Therapy
220 schema:publisher Springer Nature
221 rdf:type schema:Periodical
222 sg:person.01146757520.17 schema:affiliation grid-institutes:grid.6214.1
223 schema:familyName Doggen
224 schema:givenName Carine J. M.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146757520.17
226 rdf:type schema:Person
227 sg:person.012615570741.59 schema:affiliation grid-institutes:grid.417370.6
228 schema:familyName Linssen
229 schema:givenName Gerard C. M.
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012615570741.59
231 rdf:type schema:Person
232 sg:person.01371270365.96 schema:affiliation grid-institutes:grid.415214.7
233 schema:familyName Hartmann
234 schema:givenName Marc
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371270365.96
236 rdf:type schema:Person
237 sg:person.0600054325.83 schema:affiliation grid-institutes:grid.6214.1
238 schema:familyName von Birgelen
239 schema:givenName Clemens
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600054325.83
241 rdf:type schema:Person
242 sg:person.0611676220.78 schema:affiliation grid-institutes:grid.415214.7
243 schema:familyName van der Heijden
244 schema:givenName Liefke C.
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611676220.78
246 rdf:type schema:Person
247 sg:person.0622022030.42 schema:affiliation grid-institutes:grid.413972.a
248 schema:familyName Scholte
249 schema:givenName Martijn
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622022030.42
251 rdf:type schema:Person
252 sg:person.0634373652.04 schema:affiliation grid-institutes:grid.413591.b
253 schema:familyName Schotborgh
254 schema:givenName Carl E.
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634373652.04
256 rdf:type schema:Person
257 sg:person.0660011420.13 schema:affiliation grid-institutes:grid.415214.7
258 schema:familyName Kok
259 schema:givenName Marlies M.
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660011420.13
261 rdf:type schema:Person
262 sg:person.07360604275.78 schema:affiliation grid-institutes:grid.415214.7
263 schema:familyName Zocca
264 schema:givenName Paolo
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07360604275.78
266 rdf:type schema:Person
267 sg:person.0752260563.26 schema:affiliation grid-institutes:grid.415930.a
268 schema:familyName Danse
269 schema:givenName Peter W.
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752260563.26
271 rdf:type schema:Person
272 sg:pub.10.1007/s10557-014-6528-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004274264
273 https://doi.org/10.1007/s10557-014-6528-7
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/s41598-017-14247-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092446402
276 https://doi.org/10.1038/s41598-017-14247-6
277 rdf:type schema:CreativeWork
278 grid-institutes:grid.413591.b schema:alternateName Department of Cardiology, Haga Hospital, Den Haag, the Netherlands
279 schema:name Department of Cardiology, Haga Hospital, Den Haag, the Netherlands
280 rdf:type schema:Organization
281 grid-institutes:grid.413972.a schema:alternateName Department of Cardiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands
282 schema:name Department of Cardiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands
283 rdf:type schema:Organization
284 grid-institutes:grid.415214.7 schema:alternateName Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands
285 schema:name Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands
286 rdf:type schema:Organization
287 grid-institutes:grid.415930.a schema:alternateName Department of Cardiology, Rijnstate Hospital, Arnhem, the Netherlands
288 schema:name Department of Cardiology, Rijnstate Hospital, Arnhem, the Netherlands
289 rdf:type schema:Organization
290 grid-institutes:grid.417370.6 schema:alternateName Department of Cardiology, Ziekenhuisgroep Twente, Almelo and Hengelo, the Netherlands
291 schema:name Department of Cardiology, Ziekenhuisgroep Twente, Almelo and Hengelo, the Netherlands
292 rdf:type schema:Organization
293 grid-institutes:grid.6214.1 schema:alternateName Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, the Netherlands
294 schema:name Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Postbus 50.000, 7500, Enschede, KA, the Netherlands
295 Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, the Netherlands
296 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...